Peripheral Neuropathic Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Pain - GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes